UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000008438
Receipt number R000009909
Scientific Title Endoscopic ultrasound guided-fine needle aspiration for patient with suspected branch type intraductal papillary mucinous neoplasms
Date of disclosure of the study information 2012/07/15
Last modified on 2014/01/14 16:44:36

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Endoscopic ultrasound guided-fine needle aspiration for patient with suspected branch type intraductal papillary mucinous neoplasms

Acronym

EUS-FNA for patient with suspected branch type IPMN

Scientific Title

Endoscopic ultrasound guided-fine needle aspiration for patient with suspected branch type intraductal papillary mucinous neoplasms

Scientific Title:Acronym

EUS-FNA for patient with suspected branch type IPMN

Region

Japan


Condition

Condition

Branch duct type intraductal papillary mucinous neoplasms

Classification by specialty

Hepato-biliary-pancreatic medicine

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

1. Evaluation of diagnostic accuracy in EUS-FNA for pancreatic cystic lesions.
2. Extraction of predictive factors about progression of lesions.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

1. Adequate sample collecion rate

Key secondary outcomes

2. Comparision of hisitopathological findings and immunohistochemical profile between EUS-FNA specimen and surgically resected specimen in patients with surgical resection.
3. Extraction of predictive factors about tumor progression in patients with diagnosed as benign IPMN and managed by observation.
4. Cyst fluid analysis using proteomics


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

1. Patient with suspected branch type IPMN on MRCP and CT
2. Patients with written informed consent.

Key exclusion criteria

1. Patients with severely impaired organ function.
2. Patients with bleeding tendency (Plt < 50000, PT INR >= 1.5).
3. Patients with renal dysfunction (Cre >= 2.0).
4. Patient with allergy for contrast medium.
5. Patient who cant undergo MRCP because of metal inplant.
6. Patients with pregnancy.
7. Patients with malignant lesion in other organs.
8. Patients with active infection.
9. Patients with PS 4.
10. Patients with consciousness disorder.
11. Patients considered ineligible for this study.

Target sample size

80


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Tsuyoshi Hayashi

Organization

Sapporo Medical University

Division name

Fourth Department of Internal Medicine

Zip code


Address

South-1, West-16, Chuo-ku Sapporo, Hokkaido, 060-8556, Japan.

TEL

011-611-2111

Email

thayashi69@sapmed.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name Tsuyoshi Hayashi

Organization

Sapporo Medical University

Division name

Fourth Department of Internal Medicine

Zip code


Address

S1, W16, Chuoku, Sapporo, Hokkaido, Japan

TEL

011-611-2111

Homepage URL


Email

thayashi69@sapmed.ac.jp


Sponsor or person

Institute

Sapporo Medical University Fourth Department of Internal Medicine

Institute

Department

Personal name



Funding Source

Organization

Sapporo Medical University Fourth Department of Internal Medicine

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2012 Year 07 Month 15 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Enrolling by invitation

Date of protocol fixation

2012 Year 07 Month 01 Day

Date of IRB


Anticipated trial start date

2012 Year 07 Month 15 Day

Last follow-up date


Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

When Patient is diagnosed as malignancy or suspicious for malignancy, typical surgical resction is performed.
When Patient is diagnosed as benign, regular image examination (contrast enhanced CT, MRCP and EUS) was performed for two yaers.


Management information

Registered date

2012 Year 07 Month 14 Day

Last modified on

2014 Year 01 Month 14 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000009909


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name